Single-Dose Anticoagulant Promising in Knee Replacement

12:03 EST 14 Jan 2020 | MedPageToday

]]>(MedPage Today) -- A monoclonal antibody against coagulation factor XI is being studied to prevent venous thromboembolism (VTE) after knee arthroplasty, with a phase II study suggesting that a single, modest dose could be on par with standard therapy...

Original Article: Single-Dose Anticoagulant Promising in Knee Replacement


More From BioPortfolio on "Single-Dose Anticoagulant Promising in Knee Replacement"

Quick Search

Relevant Topics

An antibody is a protein produced by the body's immune system when it detects harmful substances, called antigens. Examples of antigens include microorganisms (such as bacteria, fungi, parasites, and viruses) and chemicals. Antibodies may be produc...

Joint Disorders
A joint is where two or more bones come together, like the knee, hip, elbow, or shoulder. Joints can be damaged by many types of injuries or diseases, including Arthritis - inflammation of a joint causes pain, stiffness, and swelling with ...

Arthroplasty is a surgical procedure to restore the integrity and function of a joint. A joint can be restored by resurfacing the bones. An artificial joint (called a prosthesis) may also be used. Various types of arthritis may affect the joints. Osteo...